Degrons at the C terminus of the pathogenic but not the nonpathogenic hantavirus G1 tail direct proteasomal degradation

Journal of Virology

Volumn 81, Issue 8, 2007, Pages 4323-4330

  Sen, Nandini ^a,b   Sen, Adrish ^a,b   Mackow, Erich R ^a,b,c  

^a STONY BROOK UNIVERSITY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; GREEN FLUORESCENT PROTEIN; PROTEASOME;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CRUSH SYNDROME; HANTAVIRUS; HANTAVIRUS PULMONARY SYNDROME; HYDROPHOBICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN STABILITY; SIGNAL TRANSDUCTION; UBIQUITINATION; VIRUS HEMORRHAGIC FEVER; VIRUS PATHOGENESIS; VIRUS VIRULENCE;

AMINO ACID MOTIFS; AMINO ACID SUBSTITUTION; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HANTAAN VIRUS; HANTAVIRUS; HUMANS; HYDROPHOBICITY; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN STRUCTURE, TERTIARY; VIRAL ENVELOPE PROTEINS; VIRULENCE;

HANTAAN VIRUS; HANTAVIRUS; PROSPECT HILL VIRUS;

EID: 34247097542     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02279-06     Document Type: Article

References (44)

1. Alff, P. J., I. N. Gavrilovskaya, E. Gorbunova, K. Endriss, Y. Chong, E. Geimonen, N. Sen, N. C. Reich, and E. R. Mackow. 2006. The pathogenic NY-1 hantavirus G1 cytoplasmic tail inhibits RIG-I- and TBK-1-directed interferon responses. J. Virol. 80:9676-9686.
2. Barel, M. T., G. C. Hassink, S. van Voorden, and E. J. Wiertz. 2006. Human cytomegalovirus-encoded US2 and US11 target unassembled MHC class I heavy chains for degradation. Mol. Immunol. 43:1258-1266.
3. Barro, M., and J. T. Patton. 2005. Rotavirus nonstructural protein 1 subverts innate immune response by inducing degradation of IFN regulatory factor 3. Proc. Natl. Acad. Sci. USA 102:4114-4119.
4. Bishop, D. 1996. Biology and molecular biology of bunyaviruses, p. 19-62. In R. M. Elliot (ed.), The Bunyaviridae. Plenum Press, New York, NY.
5. Bogusz, A. M., D. R. Brickley, T. Pew, and S. D. Ganzen. 2006. A novel N-terminal hydrophobic motif mediates constitutive degradation of serum-and glucocorticoid-induced kinase-1 by the ubiquitin-proteasome pathway. FEBS J. 273:2913-2928.
6. Batten, J., K. Mirowsky, D. Kusewitt, C. Ye, K. Gattlieb, J. Prescott, and B. Hjelle. 2003. Persistent Sin Nombre virus infection in the deer mouse (Peromyscus maniculatus) model: sites of replication and strand-specific expression. J. Virol. 77:1540-1550.
7. Boutell, C., S. Sadis, and R. D. Everett. 2002. Herpes simplex virus type 1 immediate-early protein ICPO and its isolated RING finger domain act as ubiquitin E3 ligases in vitro. J. Virol. 76:841-850.
8. Cadwell, K., and L. Coscoy. 2005. Ubiquitination on nonlysine residues by a viral E3 ubiquitin ligase. Science 309:127-130.
9. Cosgriff, T. M. 1991. Mechanisms of disease in Hantavirus infection: pathophysiology of hemorrhagic fever with renal syndrome. Rev. Infect. Dis. 13:97-107.
10. Crook, T., J. A. Tidy, and K. H. Vousden. 1991. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation. Cell 67:547-556.
11. Duchin, J. S., F. T. Koster, C. J. Peters, G. L. Simpson, B. Tempest, S. R. Zaki, T. G. Ksiazek, P. E. Rollin, S. Nichol, E. T. Umland, et al. 1994. Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. N. Engl. J. Med. 330:949-955.
12. Ehrlich, R. 1997. Modulation of antigen processing and presentation by persistent virus infections and in tumors. Hum. Immunol. 54:104-116.
13. Flinn, E. M., C. M. Busch, and A. P. Wright. 1998. myc boxes, which are conserved in myc family proteins, are signals for protein degradation via the proteasome. Mol. Cell. Biol. 18:5961-5969.
14. Gardner, R. G., and R. Y. Hampton. 1999. A 'distributed degron' allows regulated entry into the ER degradation pathway. EMBO J. 18:5994-6004.
15. Gavrilovskaya, I. N., N. S. Apekina, A. Myasnikov Yu, A. D. Bernshtein, E. V. Ryltseva, E. A. Gorbachkova, and M. P. Chumakov. 1983. Features of circulation of hemorrhagic fever with renal syndrome (HFRS) virus among small mammals in the European U.S.S.R. Arch. Virol. 75:313-316.
16. Geimonen, E., I. Fernandez, I. N. Gavrilovskaya, and E. R. Mackow. 2003. Tyrosine residues direct the ubiquitination and degradation of the NY-1 hantavirus G1 cytoplasmic tail. J. Virol. 77:10760-10768.
17. Geimonen, E., R. LaMonica, K. Springer, Y. Farooqui, I. N. Gavrilovskaya, and E. R. Mackow. 2003. Hantavirus pulmonary syndrome-associated hantaviruses contain conserved and functional ITAM signaling elements. J. Virol. 77:1638-1643.
18. Geimonen, E., S. Neff, T. Raymond, S. S. Kocer, I. N. Gavrilovskaya, and E. R. Mackow. 2002. Pathogenic and nonpathogenic hantaviruses differentially regulate endothelial cell responses. Proc. Natl. Acad. Sci. USA 99:13837-13842.
19. Herbst, A., S. E. Salghetti, S. Y. Kim, and W. P. Tansey. 2004. Multiple cell-type-specific elements regulate Myc protein stability. Oncogene 23:3863-3871.
20. Hochstrasser, M., and A. Varshavsky. 1990. In vivo degradation of a transcriptional regulator: the yeast alpha 2 repressor. Cell 61:697-708.
21. Huang, J., Q. Huang, X. Zhou, M. M. Shen, A. Yen, S. X. Yu, G. Dong, K. Qu, P. Huang, E. M. Anderson, S. Daniel-Issakani, R. M. Buller, D. G. Payan, and H. H. Lu. 2004. The poxvirus p28 virulence factor is an E3 ubiquitin ligase. J. Biol. Chem. 279:54110-54116.
22. Ishido, S., C. Wang, B. S. Lee, G. B. Cohen, and J. U. Jung. 2000. Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins. J. Virol. 74:5300-5309.
23. Johnson, P. R., R. Swanson, L. Rakhilina, and M. Hochstrasser. 1998. Degradation signal masking by heterodimerization of MATα2 and MATa1 blocks their mutual destruction by the ubiquitin-proteasome pathway. Cell 94:217-227.
24. Lee, H. W. 1982. Hemorrhagic fever with renal syndrome (HFRS). Scand. J. Infect. Dis. Suppl. 36:82-85.
25. Lober, C., B. Anheier, S. Lindow, H. D. Klenk, and H. Feldmann. 2001. The Hantaan virus glycoprotein precursor is cleaved at the conserved pentapeptide WAASA. Virology 289:224-229.
26. Lorick, K. L., J. P. Jensen, S. Fang, A. M. Ong, S. Hatakeyama, and A. M. Weissman. 1999. RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proc. Natl. Acad. Sci. USA 96:11364-11369.
27. Mills, J. N., J. M. Johnson, T. G. Ksiazek, B. A. Ellis, P. E. Rollin, T. L. Yates, M. O. Mann, M. R. Johnson, M. L. Campbell, J. Miyashiro, M. Patrick, M. Zyzak, D. Lavender, M. G. Novak, K. Schmidt, C. J. Peters, and J. E. Childs. 1998. A survey of hantavirus antibody in small-mammal populations in selected United States National Parks. Am. J. Trop. Med. Hyg. 58:525-532.
28. Nichol, S. T., C. F. Spiropoulou, S. Morzunov, P. E. Rollin, T. G. Ksiazek, H. Feldmann, A. Sanchez, J. Childs, S. Zaki, and C. J. Peters. 1993. Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science 262:914-917.
29. Nuti, M., M. Agostini, E. Albini, T. Avsic-Zupanc, and A. Kraigher. 1992. Antibodies against the Hantaan virus in Italian ex-soldiers stationed in the Balkans during World War II. Ann. Ig. 4:23-28. (In Italian.)
30. Oresic, K., V. Noriega, L. Andrews, and D. Tortorella. 2006. A structural determinant of human cytomegalovirus US2 dictates the down-regulation of class I major histocompatibility molecules. J. Biol. Chem. 281:19395-19406.
31. Pensiero, M. N., and J. Hay. 1992. The Hantaan virus M-segment glycoproteins G1 and G2 can be expressed independently. J. Virol. 66:1907-1914.
32. Plyusnin, A., O. Vapalahti, and A. Vaheri. 1996. Hantaviruses: genome structure, expression and evolution. J. Gen. Virol. 77:2677-2687.
33. Salghetti, S. E., S. Y. Kim, and W. P. Tansey. 1999. Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc. EMBO J. 18:717-726.
34. Schmaljohn, C. 1996. Bunyaviridae and their replication, p. 1447-1471. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed., vol. 1. Lippincott-Raven Publishers, Philadelphia, PA.
35. Schmaljohn, C., and B. Hjelle. 1997. Hantaviruses: a global disease problem. Emerg. Infect. Dis. 3:95-104.
36. Song, J. W., L. J. Baek, I. N. Gavrilovskaya, E. R. Mackow, B. Hjelle, and R. Yanagihara. 1996. Sequence analysis of the complete S genomic segment of a newly identified hantavirus isolated from the white-footed mouse (Peromyscus leucopus): phylogenetic relationship with other sigmodontine rodent-borne hantaviruses. Virus Genes 12:249-256.
37. Sosa-Estani, S., V. P. Martinez, M. Gonzalez Della Valle, A. Edelstein, S. Miguel, P. J. Padula, M. L. Cacase, and E. L. Segura. 2002. Hantavirus in human and rodent population in an endemic area for hantavirus pulmonary syndrome in Argentina. Medicina (Buenos Aires). 62:1-8. (In Spanish.)
38. Spiropoulou, C. F., C. S. Goldsmith, T. R. Shoemaker, C. J. Peters, and R. W. Compans. 2003. Sin Nombre virus glycoprotein trafficking. Virology 308:48-63.
39. Tager Frey, M., P. C. Vial, C. H. Castillo, P. M. Godoy, B. Hjelle, and M. G. Ferres. 2003. Hantavirus prevalence in the IX Region of Chile. Emerg. Infect. Dis. 9:827-832.
40. van der Wal, F. J., M. Kikkert, and E. Wiertz. 2002. The HCMV gene products US2 and US11 target MHC class I molecules for degradation in the cytosol. Curr. Top. Microbiol. Immunol. 269:37-55.
41. Vapalahti, O., A. Lundkvist, S. K. Kukkonen, Y. Cheng, M. Gilljam, M. Kanerva, T. Manni, M. Pejcoch, J. Niemimaa, A. Kaikusalo, H. Henttonen, A. Vaheri, and A. Plyusnin. 1996. Isolation and characterization of Tula virus, a distinct serotype in the genus Hantavirus, family Bunyaviridae. J. Gen. Virol. 77:3063-3067.
42. Varshavsky, A. 1991. Naming a targeting signal. Cell 64:13-15.
43. Wells, R. M., J. Young, R. J. Williams, L. R. Armstrong, K. Busico, A. S. Khan, T. G. Ksiazek, P. E. Rollin, S. R. Zaki, S. T. Nichol, and C. J. Peters. 1997. Hantavirus transmission in the United States. Emerg. Infect. Dis. 3:361-365.
44. Zaki, S. R., P. W. Greer, L. M. Coffield, C. S. Goldsmith, K. B. Nolte, K. Foucar, R. M. Feddersen, R. E. Zumwalt, G. L. Miller, A. S. Khan, et al. 1995. Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease. Am. J. Pathol. 146:552-579.